Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Flack

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
Vascular Health and Risk Management|January 14, 2012
Benefits of once-daily therapies in the treatment of hypertensionJohn M Flack, Samar A Nasser
Current Hypertension Reports|May 2, 2003
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diureticJohn M Flack, Samar A Nasser,
Journal of Clinical Hypertension (Greenwich, Conn.)|January 11, 2011
Treatment considerations with aldosterone receptor antagonistsDomenic A Sica, John M Flack
Journal of Clinical Hypertension (Greenwich, Conn.)|April 29, 2005
Therapeutic considerations in the African-American patient with hypertension: considerations with calcium channel blocker therapyJohn M Flack, Domenic A Sica
Expert Review of Cardiovascular Therapy|November 30, 2012
Should African-Americans with elevated blood pressure be routinely screened for hypertensive heart disease?Phillip D Levy, John M Flack
Journal of the American Academy of Nurse Practitioners|March 19, 2003
Diagnosis and treatment of hypertension in children and adolescentsRosalind M Peters, John M Flack
American Journal of Hypertension|August 31, 2016
The Case for Low Blood Pressure TargetsJohn M Flack, Carlos Nolasco, Phillip Levy
American Journal of Hypertension|June 15, 2022
Influence of Obesity on Blood Pressure Responses to Antihypertensive Drug Therapy in an Urban Hypertension Specialty ClinicPriyanka Bhandari, Vivek Prakash, John M Flack
Trends in Cardiovascular Medicine|December 13, 2023
Editorial commentary: Highlighting important (selected) issues in hypertension therapeuticsJohn M Flack, Stephanie Bitner, Michael Buhnerkempe
American Journal of Hypertension|July 18, 2024
Evolving the Role of Black Race in Hypertension TherapeuticsJohn M Flack, Stephanie Bitner, Michael Buhnerkempe
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
Vascular Health and Risk Management|January 14, 2012
Benefits of once-daily therapies in the treatment of hypertensionJohn M Flack, Samar A Nasser
Current Hypertension Reports|May 2, 2003
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diureticJohn M Flack, Samar A Nasser,
Journal of Clinical Hypertension (Greenwich, Conn.)|January 11, 2011
Treatment considerations with aldosterone receptor antagonistsDomenic A Sica, John M Flack
Journal of Clinical Hypertension (Greenwich, Conn.)|April 29, 2005
Therapeutic considerations in the African-American patient with hypertension: considerations with calcium channel blocker therapyJohn M Flack, Domenic A Sica
Expert Review of Cardiovascular Therapy|November 30, 2012
Should African-Americans with elevated blood pressure be routinely screened for hypertensive heart disease?Phillip D Levy, John M Flack
Journal of the American Academy of Nurse Practitioners|March 19, 2003
Diagnosis and treatment of hypertension in children and adolescentsRosalind M Peters, John M Flack
American Journal of Hypertension|August 31, 2016
The Case for Low Blood Pressure TargetsJohn M Flack, Carlos Nolasco, Phillip Levy
American Journal of Hypertension|June 15, 2022
Influence of Obesity on Blood Pressure Responses to Antihypertensive Drug Therapy in an Urban Hypertension Specialty ClinicPriyanka Bhandari, Vivek Prakash, John M Flack
Trends in Cardiovascular Medicine|December 13, 2023
Editorial commentary: Highlighting important (selected) issues in hypertension therapeuticsJohn M Flack, Stephanie Bitner, Michael Buhnerkempe
American Journal of Hypertension|July 18, 2024
Evolving the Role of Black Race in Hypertension TherapeuticsJohn M Flack, Stephanie Bitner, Michael Buhnerkempe
Pageof 16